Differing from studies that relied on engineered tumor cell lines with gene overexpression in B cells or APCs, our model exclusively used primary LECs, which do not express CD80 or PD-1, to show a trans interaction of CD80/PD-L1. This evidence concerns the gene CD80 and neoplasm.